Design, synthesis and antistaphylococcal activity of marine pyrrole alkaloid derivatives

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 29, Issue 3, 2014, Pages 401-407

  Rane, Rajesh A ^a   Sahu, Niteshkumar U ^a   Shah, Chetan P ^a   Shah, Nishant K ^a  

^a SVKM s Narsee Monjee Institute of Management Studies   (India)

Author keywords

Antistaphylococcal activity; Bromopyrrole alkaloids; Hydrazide derivatives

Indexed keywords

4,5 DIBROMO 1 METHYL N' (3 PHENYLALLYLIDENE) 1H PYRROLE 2 CARBOHYDRAZIDE; 4,5 DIBROMO 1 METHYL N' (4 NITROBENZYLIDENE) 1H PYRROLE 2 CARBOHYDRAZIDE; 4,5 DIBROMO 1 METHYL N' (THIOPHEN 2 YLMETHYLENE) 1H PYRROLE 2 CARBOHYDRAZIDE; 4,5 DIBROMO N' (2 HYDROXY 4 METHOXYBENZYLIDENE) 1 METHYL 1H PYRROLE 2 CARBOHYDRAZIDE; 4,5 DIBROMO N' (2,5 DIHYDROXYBENZYLIDENE) 1 METHYL 1H PYRROLE 2 CARBOHYDRAZIDE; 4,5 DIBROMO N' (2,6 DICHLOROBENZYLIDENE) 1 METHYL 1H PYRROLE 2 CARBOHYDRAZIDE; 4,5 DIBROMO N' (3,4 DIMETHOXYBENZYLIDENE) 1 METHYL 1H PYRROLE 2 CARBOHYDRAZIDE; 4,5 DIBROMO N' (4 CHLOROBENZYLIDENE) 1 METHYL 1H PYRROLE 2 CARBOHYDRAZIDE; 4,5 DIBROMO N' (4 FLUOROBENZYLIDENE) 1 METHYL 1H PYRROLE 2 CARBOHYDRAZIDE; 4,5 DIBROMO N' (4 HYDROXY 3 METHOXYBENZYLIDENE) 1 METHYL 1H PYRROLE 2 CARBOHYDRAZIDE; 4,5 DIBROMO N' (4 HYDROXYBENZYLIDENE) 1 METHYL 1H PYRROLE 2 CARBOHYDRAZIDE; 4,5 DIBROMO N' (4 METHOXYBENZYLIDENE) 1 METHYL 1H PYRROLE 2 CARBOHYDRAZIDE; 4,5 DIBROMO N' (FURAN 2 YLMETHYLENE) 1 METHYL 1H PYRROLE 2 CARBOHYDRAZIDE; 4,5 DIBROMO N' BENZYLIDENE 1 METHYL 1H PYRROLE 2 CARBOHYDRAZIDE; 4,5 DIBROMO N' [4 (2,6 DICHLOROPHENOXY)BENZYLIDENE] 1 METHYL 1H PYRROLE 2 CARBOHYDRAZIDE; 4,5 DIBROMO N' [4 (DIMETHYLAMINO)BENZYLIDENE] 1 METHYL 1H PYRROLE 2 CARBOHYDRAZIDE; ALKALOID DERIVATIVE; ANTIINFECTIVE AGENT; HYDRAZIDE DERIVATIVE; HYDRAZONE DERIVATIVE; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG; VANCOMYCIN; ALKALOID; THIAZOLIDINE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIOFILM; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG SYNTHESIS; HYBRID; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; ANIMAL; ANTIBIOTIC RESISTANCE; CHEMISTRY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; SPONGE (PORIFERA); SYNTHESIS;

ALKALOIDS; ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; DRUG DESIGN; DRUG RESISTANCE, BACTERIAL; HYDRAZONES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; PORIFERA; PYRROLES; STAPHYLOCOCCUS EPIDERMIDIS; THIAZOLIDINES; VANCOMYCIN;

EID: 84900820164     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2013.793183     Document Type: Article

References (23)

1. Leclercq R. Epidemiological and resistance issues in multidrugresistant staphylococci and enterococci. Clin Microbiol Infect 2009; 15:224-31.
2. Reed SD, Friedman JY, Engemann JJ, et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. J Infect Control Hosp Epidemiol 2005;26:175-83.
3. Mohan SS, McDermott BP, Cunha BA. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin. Heart Lung 2005;34: 69-71.
4. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000;132:391-402.
5. Raad I, Hanna H, Jiang Y, et al. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 2007;51:1656-60.
6. Cirioni O, Giacometti A, Ghiselli R, et al. Prophylactic efficacy of topical temporin A and RNAIIIinhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides. Circulation 2003;108: 767-71.
7. Burton E, Gawande PV, Yakandawala N, et al. Antibiofilm activity of GlmU enzyme inhibitors against catheterassociated uropathogens. Antimicrob Agents Chemother 2006;50:1835-40.
8. Rodrigues LR, Banat IM, van der Mei HC, et al. Interference in adhesion of bacteria and yeasts isolated from explanted voice prostheses to silicone rubber by rhamnolipid biosurfactants. J Appl Microbiol 2006;100:470-80.
9. Bryers JD, Ratner BD. Bioinspired implant materials befuddle bacteria. ASM News 2004;70:232-7.
10. Aiello A, Fattorusso E, Menna M, Taglialatela-Scafati O. Modern alkaloids structure, isolation, synthesis and biology. Weinheim: Wiley-VCH; 2008:271.
11. Tasdemir D, Topaloglu B, Perozzo R, et al. Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli. Bioorg Med Chem 2007;15: 6834-45.
12. Xiong S, Pang HD, Fan J, et al. In vitro and in vivo antineoplastic activity of a novel bromopyrrole and its potential mechanism of action. Br J Pharmacol 2010;159:909-18.
13. Schillaci D, Petruso S, Cascioferro S, Raimondi MV. In vitro anti- Gram-positive and antistaphylococcal biofilm activity of newly halogenated pyrroles related to pyrrolomycins. Int J Antimicrob Agents 2008;31:380-99.
14. Rane RA, Gutte SD, Sahu NU. Synthesis and evaluation of novel 1,3,4-oxadiazole derivatives of marine bromopyrrole alkaloids as antimicrobial agent. Bioorg Med Chem Lett 2012;22:6429-32.
15. Rane RA, Sahu NU, Shah CP. Synthesis and antibiofilm activity of marine natural product-based 4-thiazolidinones derivatives. Bioorg Med Chem Lett 2012;22:7131-4.
16. Rollas S, Küçükgüzel ŞG. Biological activities of hydrazone derivatives. Molecules 2007;12:1910-39.
17. Junker LM, Clardy J. High-throughput screens for small-molecule inhibitors of Pseudomonas aeruginosa biofilm development. J Antimicrob Agents and Chemother 2007;51:3582-90.
18. Matthew A, Cockerill FR, Craig WA, et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, M7-A7. 7th ed. Vol. 26. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2006: 1-49.
19. Christensen GD, Simpson WA, Younger JA, et al. Adherence of cogulase negative Staphylococi to plastic tissue cultures: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985;22:996-1006.
20. Pan B, Huang R, Han S, et al. Design, synthesis, and antibiofilm activity of 2-arylimino-3-aryl-thiazolidine-4-ones. Bioorg Med Chem Lett 2010;20:2461-4.
21. Filoche SK, Soma K, Sissons CH. Antimicrobial effects of essential oils in combination with chlorhexidine digluconate. Oral Microbiol Immunol 2005;20:221-5.
22. Bailey DM, Johnson RE, Salvador JU. Pyrrole antibacterial agents. 1. Compounds related to pyoluteorin. J Med Chem 1973;16: 1298-300.
23. Linington RG, Williams DE, Tahir A, et al. Latonduines A and B, new alkaloids isolated from the marine sponge Stylissa carteri: structure elucidation, synthesis, and biogenetic implications. Org Lett 2003;5:2735-8.